Abloy Canada Inc. completed the acquisition of Vigil Health Solutions Inc. from a group of shareholders.
As of February 4, 2022, an interim order of the British Columbia Supreme Court has been obtained. Interim Order provides for, among other things, the calling and the holding of a special meeting holders of common shares in the capital of Vigil. Vigil will held the shareholders meeting on March 16, 2022. As of March 16, 2022, Vigil shareholders and option holders have approved the transaction. Transaction is pending receipt of the final order of the Supreme Court of British Columbia approving the Arrangement, which is anticipated to be received on or around March 21, 2022, receipt of the final approval of the TSXV and subject to the satisfaction or waiver of other conditions to closing. As of March 21, 2022, Vigil Health has obtained a final order from the British Columbia Supreme Court approving the transaction. The transaction is expected to close in March 2022. As of February 4, 2022, the transaction is expected to close on or around April 1, 2022.
Capital West Partners is acting as financial advisor and fairness opinion provider for Vigil Health Solutions Inc. Trevor Scott, Emily MacKinnon and Alain Fournier of Osler, Hoskin & Harcourt LLP acted as legal advisors to Vigil. Todd Miller of McMillan LLP acted as the legal advisor for Abloy Canada Inc. Computershare Investor Services Inc. is the transfer agent for shares of Vigil Health Solutions.
Abloy Canada Inc. completed the acquisition of Vigil Health Solutions Inc. (TSXV:VGL) from a group of shareholders on April 1, 2022. The Common Shares of Vigil Health Solutions Inc. will be delisted from the TSX Venture Exchange as of the close of trading on April 4, 2022. The Company will also submit an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the Company's public reporting requirements.